{
    "id": 19,
    "premise": "none",
    "hypothesis": "Dasatinib will need to be accessed off licence.",
    "label": "entailment",
    "explanation": "Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia.\nDasatinib may be effective in treating this patient.",
    "results": {
        "semantic validity": true,
        "premise": null,
        "hypothesis": "Dasatinib will need to be accessed off licence.",
        "refined explanation": "Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia.\nDasatinib may be effective in treating this patient.\nIf Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it will need to be accessed off licence.\nThere are conditions for which Dasatinib is not licensed, and if used for such conditions, it must be accessed off licence.\nDasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia.",
        "refined iteration": 3,
        "history explanation": [
            "0 iteration: Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia.\nDasatinib may be effective in treating this patient.",
            "1 iteration: Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia.\nDasatinib may be effective in treating this patient.\nIf Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it will need to be accessed off licence.",
            "2 iteration: Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia.\nDasatinib may be effective in treating this patient.\nIf Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it will need to be accessed off licence.\nThere are conditions for which Dasatinib is not licensed, and if used for such conditions, it must be accessed off licence.",
            "3 iteration: Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia.\nDasatinib may be effective in treating this patient.\nIf Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it will need to be accessed off licence.\nThere are conditions for which Dasatinib is not licensed, and if used for such conditions, it must be accessed off licence.\nDasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia."
        ],
        "history semantic validity": [
            "0 iteration: False",
            "1 iteration: False",
            "2 iteration: False",
            "3 iteration: True"
        ],
        "history critique output": [
            "0 iteration: {'syntactic validity': True, 'error code': '(* Explanation 1 provides conditions under which Dasatinib is licensed. *)\\n(* Explanation 2 suggests Dasatinib may be effective, but does not confirm licensing for this specific patient. *)\\n(* We need to show that Dasatinib will be accessed off licence, implying it is not licensed for this specific use. *)\\n(* Since the hypothesis is about accessing off licence, we assume that neither A nor B holds for this specific case. *)\\n(* Therefore, we conclude that Dasatinib will need to be accessed off licence. *)\\nthen have \"\u2203e. Accessed e \u2227 Patient e x \u2227 OffLicence e\" sledgehammer', 'solving time': 103.88021302223206, 'proof tactics': [], 'code': 'theory clinical_19_0\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  Licensed :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Use :: \"entity \u21d2 bool\"\\n  ChronicMyeloidLeukaemia :: \"entity \u21d2 bool\"\\n  RelapsedAcuteLymphoblasticLeukaemia :: \"entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Treating :: \"event \u21d2 bool\"\\n  Accessed :: \"event \u21d2 bool\"\\n  OffLicence :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Dasatinib x \u2227 Licensed e \u2227 Patient e x \u2227 Use y \u2227 ChronicMyeloidLeukaemia y \u2227 Use z \u2227 RelapsedAcuteLymphoblasticLeukaemia z\"\\n\\n(* Explanation 2: Dasatinib may be effective in treating this patient. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e1 e2. Dasatinib x \u2227 Effective e1 \u2227 Patient e1 x \u2227 Treating e2 \u2227 Patient e2 y\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x\"\\n  (* Hypothesis: Dasatinib will need to be accessed off licence. *)\\n  shows \"\u2203x e. Dasatinib x \u2227 Accessed e \u2227 Patient e x \u2227 OffLicence e\"\\nproof -\\n  (* From the premise, we have the known information about Dasatinib. *)\\n  from asm have \"Dasatinib x\" <ATP>\\n  (* Explanation 1 provides conditions under which Dasatinib is licensed. *)\\n  (* Explanation 2 suggests Dasatinib may be effective, but does not confirm licensing for this specific patient. *)\\n  (* We need to show that Dasatinib will be accessed off licence, implying it is not licensed for this specific use. *)\\n  (* Since the hypothesis is about accessing off licence, we assume that neither A nor B holds for this specific case. *)\\n  (* Therefore, we conclude that Dasatinib will need to be accessed off licence. *)\\n  then have \"\u2203e. Accessed e \u2227 Patient e x \u2227 OffLicence e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Dasatinib is licensed for use in chronic myeloid leukaemia (from Explanatory Sentence 1)\\nB: Dasatinib is licensed for use in relapsed acute lymphoblastic leukaemia (from Explanatory Sentence 1)\\nC: Dasatinib may be effective in treating this patient (from Explanatory Sentence 2)\\n\\nLogical Relations:\\nOr(A, B)\\nA | B\\n--------\\nImplies(Or(A, B), C)\\nImplies(A | B, Dasatinib may be effective in treating this patient)\\n--------\\n\\nDerived Implications:\\nImplies(Not(C), A)\\nImplies(Not(Dasatinib may be effective in treating this patient), Dasatinib is licensed for use in chronic myeloid leukaemia)\\n--------\\nImplies(Not(C), Not(B))\\nImplies(Not(Dasatinib may be effective in treating this patient), Not(Dasatinib is licensed for use in relapsed acute lymphoblastic leukaemia))\\n--------\\nImplies(Not(C), B)\\nImplies(Not(Dasatinib may be effective in treating this patient), Dasatinib is licensed for use in relapsed acute lymphoblastic leukaemia)\\n--------\\nImplies(A, C)\\nImplies(Dasatinib is licensed for use in chronic myeloid leukaemia, Dasatinib may be effective in treating this patient)\\n--------\\nImplies(B, C)\\nImplies(Dasatinib is licensed for use in relapsed acute lymphoblastic leukaemia, Dasatinib may be effective in treating this patient)\\n--------\\nImplies(Not(A), C)\\nImplies(Not(Dasatinib is licensed for use in chronic myeloid leukaemia), Dasatinib may be effective in treating this patient)\\n--------\\nImplies(Not(C), Not(A))\\nImplies(Not(Dasatinib may be effective in treating this patient), Not(Dasatinib is licensed for use in chronic myeloid leukaemia))\\n--------\\nImplies(Not(C), C)\\nImplies(Not(Dasatinib may be effective in treating this patient), Dasatinib may be effective in treating this patient)\\n--------\\nImplies(Not(B), C)\\nImplies(Not(Dasatinib is licensed for use in relapsed acute lymphoblastic leukaemia), Dasatinib may be effective in treating this patient)\\n--------\\n'}",
            "1 iteration: {'syntactic validity': True, 'error code': '(* We need to show that Dasatinib is used for conditions other than the specified ones to apply this conditional. *)\\n(* Since the premise does not specify the conditions, we assume the use is for other conditions. *)\\nhave \"\u00acChronicMyeloidLeukaemia y \u2227 \u00acRelapsedAcuteLymphoblasticLeukaemia z\" sledgehammer', 'solving time': 104.21601152420044, 'proof tactics': [], 'code': 'theory clinical_19_1\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  Licensed :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Use :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  ChronicMyeloidLeukaemia :: \"entity \u21d2 bool\"\\n  RelapsedAcuteLymphoblasticLeukaemia :: \"entity \u21d2 bool\"\\n  In :: \"event \u21d2 entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Treating :: \"event \u21d2 bool\"\\n  Used :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n  Accessed :: \"event \u21d2 bool\"\\n  OffLicence :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e1 e2. Dasatinib x \u2227 Licensed e1 \u2227 Patient e1 x \u2227 Use e2 \u2227 Agent e2 x \u2227 (ChronicMyeloidLeukaemia y \u2228 RelapsedAcuteLymphoblasticLeukaemia z) \u2227 In e2 y \u2227 In e2 z\"\\n\\n(* Explanation 2: Dasatinib may be effective in treating this patient. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e1 e2. Dasatinib x \u2227 Effective e1 \u2227 Agent e1 x \u2227 Treating e2 \u2227 Agent e2 x \u2227 Patient e2 y\"\\n\\n(* Explanation 3: If Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it will need to be accessed off licence. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e1 e2. Dasatinib x \u2227 (\u00acChronicMyeloidLeukaemia y \u2227 \u00acRelapsedAcuteLymphoblasticLeukaemia z) \u2227 Used e1 \u2227 Agent e1 x \u2227 For e1 y \u2227 For e1 z \u27f6 (Accessed e2 \u2227 Patient e2 x \u2227 OffLicence e2)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x\"\\n  (* Hypothesis: Dasatinib will need to be accessed off licence. *)\\n  shows \"\u2203x e. Dasatinib x \u2227 Accessed e \u2227 Patient e x \u2227 OffLicence e\"\\nproof -\\n  (* From the premise, we have the known information about Dasatinib. *)\\n  from asm have \"Dasatinib x\" <ATP>\\n  (* Explanation 3 provides a conditional statement: \\n     If Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, \\n     it will need to be accessed off licence. *)\\n  (* We need to show that Dasatinib is used for conditions other than the specified ones to apply this conditional. *)\\n  (* Since the premise does not specify the conditions, we assume the use is for other conditions. *)\\n  have \"\u00acChronicMyeloidLeukaemia y \u2227 \u00acRelapsedAcuteLymphoblasticLeukaemia z\" <ATP>\\n  (* By applying the logical relation Implies(D, E), we can infer the need for off licence access. *)\\n  then have \"Accessed e \u2227 Patient e x \u2227 OffLicence e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Dasatinib is licensed for use in chronic myeloid leukaemia (from Explanatory Sentence 1)\\nB: Dasatinib is licensed for use in relapsed acute lymphoblastic leukaemia (from Explanatory Sentence 1)\\nC: Dasatinib may be effective in treating this patient (from Explanatory Sentence 2)\\nD: Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia (from Explanatory Sentence 3)\\nE: Dasatinib will need to be accessed off licence (from Explanatory Sentence 3)\\n\\nLogical Relations:\\nImplies(D, E)\\nImplies(Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, Dasatinib will need to be accessed off licence)\\n--------\\n\\nDerived Implications:\\n'}",
            "2 iteration: {'syntactic validity': True, 'error code': '(* Explanation 3 provides a logical relation: Implies(D, E), which states that if Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it needs to be accessed off licence. *)\\n(* Explanation 4 provides another logical relation: Implies(F, E), which states that if Dasatinib is used for conditions for which it is not licensed, it needs to be accessed off licence. *)\\n(* Since we have no specific information about the conditions, we can assume that Dasatinib is used for conditions other than the licensed ones or for unlicensed conditions. *)\\n(* Therefore, we can infer that Dasatinib needs to be accessed off licence. *)\\nthen have \"\u2203e. Accessed e \u2227 Patient e x \u2227 OffLicence e\" sledgehammer', 'solving time': 103.48432946205139, 'proof tactics': [], 'code': 'theory clinical_19_2\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  Licensed :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  Use :: \"entity \u21d2 bool\"\\n  In :: \"entity \u21d2 entity \u21d2 bool\"\\n  ChronicMyeloidLeukaemia :: \"entity \u21d2 bool\"\\n  RelapsedAcuteLymphoblasticLeukaemia :: \"entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Treating :: \"event \u21d2 bool\"\\n  thisPatient :: \"entity\"\\n  Used :: \"event \u21d2 bool\"\\n  Condition :: \"entity \u21d2 bool\"\\n  OtherThan :: \"entity \u21d2 entity \u21d2 bool\"\\n  Accessed :: \"event \u21d2 bool\"\\n  OffLicence :: \"event \u21d2 bool\"\\n  For :: \"event \u21d2 entity \u21d2 bool\"\\n\\n(* Explanation 1: Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y z e. Dasatinib x \u2227 Licensed e \u2227 Patient e x \u2227 (Use y \u2227 In y z \u2227 (ChronicMyeloidLeukaemia z \u2228 RelapsedAcuteLymphoblasticLeukaemia z))\"\\n\\n(* Explanation 2: Dasatinib may be effective in treating this patient. *)\\naxiomatization where\\n  explanation_2: \"\u2203x e1 e2. Dasatinib x \u2227 Effective e1 \u2227 Patient e1 x \u2227 Treating e2 \u2227 Patient e2 thisPatient\"\\n\\n(* Explanation 3: If Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it will need to be accessed off licence. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y z e1 e2. Dasatinib x \u2227 Used e1 \u2227 Patient e1 x \u2227 Condition y \u2227 OtherThan y z \u2227 (ChronicMyeloidLeukaemia z \u2228 RelapsedAcuteLymphoblasticLeukaemia z) \u27f6 (Accessed e2 \u2227 Patient e2 x \u2227 OffLicence e2)\"\\n\\n(* Explanation 4: There are conditions for which Dasatinib is not licensed, and if used for such conditions, it must be accessed off licence. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y e1 e2. Condition x \u2227 Dasatinib y \u2227 \u00acLicensed e1 \u2227 Patient e1 y \u2227 For e1 x \u2227 (Used e2 \u2227 Patient e2 y \u2227 For e2 x \u27f6 (Accessed e2 \u2227 OffLicence e2))\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x\"\\n  (* Hypothesis: Dasatinib will need to be accessed off licence. *)\\n  shows \"\u2203x e. Dasatinib x \u2227 Accessed e \u2227 Patient e x \u2227 OffLicence e\"\\nproof -\\n  (* From the premise, we have the known information about Dasatinib. *)\\n  from asm have \"Dasatinib x\" <ATP>\\n  (* Explanation 3 provides a logical relation: Implies(D, E), which states that if Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it needs to be accessed off licence. *)\\n  (* Explanation 4 provides another logical relation: Implies(F, E), which states that if Dasatinib is used for conditions for which it is not licensed, it needs to be accessed off licence. *)\\n  (* Since we have no specific information about the conditions, we can assume that Dasatinib is used for conditions other than the licensed ones or for unlicensed conditions. *)\\n  (* Therefore, we can infer that Dasatinib needs to be accessed off licence. *)\\n  then have \"\u2203e. Accessed e \u2227 Patient e x \u2227 OffLicence e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Dasatinib is licensed for use in chronic myeloid leukaemia (from Explanatory Sentence 1)\\nB: Dasatinib is licensed for use in relapsed acute lymphoblastic leukaemia (from Explanatory Sentence 1)\\nC: Dasatinib may be effective in treating this patient (from Explanatory Sentence 2)\\nD: Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia (from Explanatory Sentence 3)\\nE: Dasatinib needs to be accessed off licence (from Explanatory Sentence 3 and 4)\\nF: Dasatinib is used for conditions for which it is not licensed (from Explanatory Sentence 4)\\n\\nLogical Relations:\\nImplies(D, E)\\nImplies(Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, Dasatinib needs to be accessed off licence)\\n--------\\nImplies(F, E)\\nImplies(Dasatinib is used for conditions for which it is not licensed, Dasatinib needs to be accessed off licence)\\n--------\\n\\nDerived Implications:\\n'}",
            "3 iteration: {'syntactic validity': True, 'error code': '', 'solving time': 33.99166417121887, 'proof tactics': ['Sledgehammering...', 'cvc4 found a proof...', 'zipperposition found a proof...', 'cvc4 found a proof...', 'vampire found a proof...', 'verit found a proof...', 'cvc4: Try this: using explanation_3 explanation_5 by blast (8 ms)', 'cvc4: Found duplicate proof', 'verit: Found duplicate proof', 'zipperposition: Found duplicate proof', 'vampire: Found duplicate proof', 'e found a proof...', 'e: Found duplicate proof', 'Done'], 'code': 'theory clinical_19_3\\nimports Main\\n\\nbegin\\n\\ntypedecl entity\\ntypedecl event\\n\\nconsts\\n  Dasatinib :: \"entity \u21d2 bool\"\\n  Licensed :: \"event \u21d2 bool\"\\n  Patient :: \"event \u21d2 entity \u21d2 bool\"\\n  UseIn :: \"event \u21d2 entity \u21d2 bool\"\\n  ChronicMyeloidLeukaemia :: \"entity \u21d2 bool\"\\n  RelapsedAcuteLymphoblasticLeukaemia :: \"entity \u21d2 bool\"\\n  Effective :: \"event \u21d2 bool\"\\n  Agent :: \"event \u21d2 entity \u21d2 bool\"\\n  Treating :: \"event \u21d2 entity \u21d2 bool\"\\n  Condition :: \"entity \u21d2 bool\"\\n  Used :: \"event \u21d2 bool\"\\n  Accessed :: \"event \u21d2 bool\"\\n  OffLicence :: \"event \u21d2 bool\"\\n\\n(* Explanation 1: Dasatinib is licensed for use in chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia. *)\\naxiomatization where\\n  explanation_1: \"\u2203x y e. Dasatinib x \u2227 Licensed e \u2227 Patient e x \u2227 (UseIn e y \u2227 (ChronicMyeloidLeukaemia y \u2228 RelapsedAcuteLymphoblasticLeukaemia y))\"\\n\\n(* Explanation 2: Dasatinib may be effective in treating this patient. *)\\naxiomatization where\\n  explanation_2: \"\u2203x y e. Dasatinib x \u2227 Patient e y \u2227 Effective e \u2227 Agent e x \u2227 Treating e y\"\\n\\n(* Explanation 3: If Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, it will need to be accessed off licence. *)\\naxiomatization where\\n  explanation_3: \"\u2200x y e1 e2. Dasatinib x \u2227 Condition y \u2227 Used e1 \u2227 Agent e1 x \u2227 Patient e1 y \u2227 \u00ac(ChronicMyeloidLeukaemia y \u2228 RelapsedAcuteLymphoblasticLeukaemia y) \u27f6 (Accessed e2 \u2227 Patient e2 x \u2227 OffLicence e2)\"\\n\\n(* Explanation 4: There are conditions for which Dasatinib is not licensed, and if used for such conditions, it must be accessed off licence. *)\\naxiomatization where\\n  explanation_4: \"\u2203x y e1 e2. Condition y \u2227 Dasatinib x \u2227 \u00acLicensed e1 \u2227 Patient e1 x \u2227 Used e2 \u2227 Agent e2 x \u2227 Patient e2 y \u27f6 (Accessed e2 \u2227 OffLicence e2)\"\\n\\n(* Explanation 5: Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia. *)\\naxiomatization where\\n  explanation_5: \"\u2203x y e. Dasatinib x \u2227 Condition y \u2227 Used e \u2227 Agent e x \u2227 Patient e y \u2227 \u00ac(ChronicMyeloidLeukaemia y \u2228 RelapsedAcuteLymphoblasticLeukaemia y)\"\\n\\ntheorem hypothesis:\\n  assumes asm: \"Dasatinib x\"\\n  (* Hypothesis: Dasatinib will need to be accessed off licence. *)\\n  shows \"\u2203x e. Dasatinib x \u2227 Accessed e \u2227 Patient e x \u2227 OffLicence e\"\\nproof -\\n  (* From Explanation 5, we know that Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia. *)\\n  from explanation_5 obtain y e where \"Dasatinib x \u2227 Condition y \u2227 Used e \u2227 Agent e x \u2227 Patient e y \u2227 \u00ac(ChronicMyeloidLeukaemia y \u2228 RelapsedAcuteLymphoblasticLeukaemia y)\" <ATP>\\n  (* This corresponds to logical proposition G. *)\\n  (* From the derived implication Implies(G, E), we can infer that Dasatinib needs to be accessed off licence. *)\\n  then have \"Accessed e \u2227 Patient e x \u2227 OffLicence e\" <ATP>\\n  then show ?thesis <ATP>\\nqed\\n\\nend\\n', 'logical information': 'Logical Propositions:\\nA: Dasatinib is licensed for use in chronic myeloid leukaemia (from Explanatory Sentence 1)\\nB: Dasatinib is licensed for use in relapsed acute lymphoblastic leukaemia (from Explanatory Sentence 1)\\nC: Dasatinib may be effective in treating this patient (from Explanatory Sentence 2)\\nD: Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia (from Explanatory Sentence 3)\\nE: Dasatinib needs to be accessed off licence (from Explanatory Sentence 3)\\nF: There are conditions for which Dasatinib is not licensed (from Explanatory Sentence 4)\\nG: Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia (from Explanatory Sentence 5)\\n\\nLogical Relations:\\nImplies(D, E)\\nImplies(Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, Dasatinib needs to be accessed off licence)\\n--------\\nImplies(F, E)\\nImplies(There are conditions for which Dasatinib is not licensed, Dasatinib needs to be accessed off licence)\\n--------\\nEquivalent(G, D)\\nEquivalent(Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia)\\n--------\\n\\nDerived Implications:\\nImplies(Not(D), Not(G))\\nImplies(Not(Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia), Not(Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia))\\n--------\\nImplies(Not(G), Not(D))\\nImplies(Not(Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia), Not(Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia))\\n--------\\nImplies(G, E)\\nImplies(Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, Dasatinib needs to be accessed off licence)\\n--------\\nImplies(G, D)\\nImplies(Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia)\\n--------\\nImplies(D, G)\\nImplies(Dasatinib is used for conditions other than chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia, Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia)\\n--------\\nImplies(Not(E), Not(G))\\nImplies(Not(Dasatinib needs to be accessed off licence), Not(Dasatinib is being used for a condition that is not chronic myeloid leukaemia or relapsed acute lymphoblastic leukaemia))\\n--------\\n'}"
        ]
    }
}